Related Experiment Video
Updated: May 26, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
The role of non-HDL cholesterol in risk stratification for coronary artery disease
Jamal S Rana1, S Matthijs Boekholdt, John J P Kastelein
1Division of Cardiology and Oppenheimer Atherosclerosis Research Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. jamal.rana@cshs.org
Insights
Non-high-density lipoprotein cholesterol (non-HDL-C) effectively measures atherogenic particles and predicts coronary heart disease (CHD) risk. Measuring non-HDL-C is crucial for cardiovascular prevention strategies.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Preventive Cardiology
Background:
- Patients on lipid-lowering therapy remain at high risk for coronary heart disease (CHD).
- Non-high-density lipoprotein cholesterol (non-HDL-C) quantifies cholesterol in all atherogenic particles.
- Non-HDL-C was introduced as a secondary therapeutic target in the ATP III guidelines for patients with elevated triglycerides.
Purpose of the Study:
- To evaluate the significance of non-HDL-C as a predictor of CHD risk.
- To assess the utility of non-HDL-C compared to other lipid markers for cardiovascular risk assessment.
- To advocate for the inclusion of non-HDL-C in routine lipid panels for guiding prevention strategies.
Main Methods:
- Analysis of data from the EPIC-Norfolk prospective population study (21,448 participants).
- Follow-up period of 11.0 years for participants aged 45-79 without diabetes or CHD.
- Assessment of the relationship between non-HDL-C levels and CHD risk, independent of LDL-C.
Main Results:
- High non-HDL-C levels were independently associated with increased CHD risk.
- Non-HDL-C reduction correlates with CHD risk reduction, similar to LDL-C.
- Non-HDL-C is a practical and cost-effective marker compared to apolipoprotein B.
Conclusions:
- Non-HDL-C is a valuable and independent predictor of cardiovascular risk.
- Routine reporting of non-HDL-C on lipid panels is recommended for improved cardiovascular prevention.
- Future guidelines should emphasize non-HDL-C for guiding therapy and risk stratification.
Abstract:
Despite aggressive lipid-lowering therapy, patients continue to be at significant risk of coronary heart disease (CHD). Assessment of non-high-density lipoprotein cholesterol (non-HDL-C) provides a measure of cholesterol contained in all atherogenic particles. In the third Adult Treatment Panel (ATP III) guidelines of the US National Cholesterol Education Program, non-HDL-C was introduced as a secondary target of therapy in persons with triglycerides ≥200 mg/dL. A recent meta-analysis of the relationship between non-HDL-C reduction and CHD risk showed non-HDL-C as an important target of therapy for CHD prevention. Most lipid-modifying drugs used as monotherapy have a 1:1 relationship between percent non-HDL-C lowering and percent CHD reduction. In the EPIC-Norfolk prospective population study, 21,448 participants without diabetes or CHD between 45 and 79 years of age were followed for 11.0 years. Participants with high non-HDL-C levels were at increased CHD risk independently of their LDL-C levels. Also, compared to apolipoprotein B, non-HDL-C appears to be a better choice given the fact that no additional tests or costs are needed and established cut points are already available. Future guidelines should emphasize the importance of non-HDL-C for guiding cardiovascular prevention strategies with an increased need to have non-HDL-C reported on routine lipid panels.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...